Clinical Trials Sponsored by DiaTech Oncology
Total 5980 results
-
CivaTech OncologyRecruitingLung Cancer | Lung Cancer Stage I | Lung Cancer Stage IIUnited States
-
CivaTech OncologyRecruitingPancreatic CancerUnited States
-
CivaTech OncologyCompletedCancer | Pancreas CancerUnited States
-
CivaTech OncologyCompleted
-
CivaTech OncologyNot yet recruitingBasal Cell Carcinoma | Squamous Cell Carcinoma of the Skin
-
CivaTech OncologyTAB ClinicalRecruitingSarcomaUnited States
-
Pierian BiosciencesDiaTech Oncology and Vanderbilt UniversityCompleted
-
Celyad Oncology SAIQVIA BiotechCompletedAML | MDSUnited States, Belgium
-
Hematology Oncology ConsultantsOrtho Biotech, Inc.UnknownMetastatic Breast CancerUnited States
-
Southeastern Gynecologic OncologyOrtho Biotech, Inc.Completed
-
Memorial Sloan Kettering Cancer CenterCivaTech OncologyActive, not recruitingAbdominal Malignancy | Pelvic MalignancyUnited States
-
Ontario Clinical Oncology Group (OCOG)Ortho Biotech, Inc.TerminatedAnemia | Lung Cancer | Non-Small-Cell Lung CarcinomaCanada
-
Aptium Oncology Research NetworkOrtho Biotech Products, L.P.Unknown
-
US Oncology ResearchOrtho Biotech, Inc.; Tibotec Pharmaceutical LimitedCompleted
-
Mural Oncology, IncImmune Oncology NetworkCompletedNon-cutaneous Squamous Cell Carcinoma of Head and NeckUnited States
-
Hirschfeld OncologyNot yet recruitingPancreatic CancerUnited States
-
Ikena OncologyRecruitingSolid Tumor | Solid Tumors, Adult | Malignant Pleural Mesothelioma (MPM) | Epithelioid Hemangioendothelioma (EHE) | NF2 Deficient Mesothelioma | Other NF2 Deficient Solid Tumors and Solid Tumors With YAP1/TAZ Fusion Genes | NF2 Deficiency | YAP1 or TAZ Gene FusionsUnited States, United Kingdom
-
Cardiff OncologyActive, not recruitingMetastatic Colorectal Cancer | Colorectal CancerUnited States
-
Elevation OncologyActive, not recruitingSarcoma | Kidney Cancer | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Cholangiocarcinoma | Bile Duct Cancer | Bladder Cancer | Metastatic Solid Tumor | Gallbladder Cancer | Uterine Cancer | Locally Advanced Solid TumorUnited States, Korea, Republic of, Australia, Canada
-
CureLab OncologyActive, not recruitingOvarian Cancer | Platinum-resistant Ovarian CancerBelarus
-
Strata OncologyEnrolling by invitation
-
Que OncologyCompleted
-
Bruckner OncologyCompletedPancreatic CancerUnited States
-
Ikena OncologyRecruitingColorectal Cancer | Pancreatic Cancer | Thyroid Carcinoma | Solid Tumor, Adult | Malignant Melanoma | Non-Small Cell Lung Carcinoma | BRAF Gene Mutation | Gliomas, Malignant | Ras (Kras or Nras) Gene Mutation | CRAF Gene MutationUnited States
-
Elevation OncologyRecruitingNeoplasms | Neoplasms by Site | Gastrointestinal Neoplasms | Digestive System Neoplasm | Pancreas Neoplasm | Stomach NeoplasmUnited States, Japan
-
Cardiff OncologyCompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Cardiff OncologyCompletedAcute Myeloid LeukemiaUnited States
-
Surface OncologyCompletedHematologic Cancers | Advanced Solid CancersUnited States, Canada
-
Elucida OncologyRecruitingOvarian Diseases | Ovarian Neoplasms | Ovarian Cancer | Ovarian Epithelial Cancer | Fallopian Tube Cancer | Endometrial Neoplasms | Endometrial Cancer | Endometrial Clear Cell Adenocarcinoma | Ovarian Carcinoma | Endometrial Adenocarcinoma | Peritoneal Cancer | Endometrioid Adenocarcinoma | Ovarian Adenocarcinoma | Ovarian Serous Adenocarcinoma and other conditionsUnited States
-
Strata OncologyRecruitingLymphoma | Cancer | Adult Solid Tumor | Multiple MyelomaUnited States
-
Cardiff OncologyCompletedMetastatic Colorectal Cancer | KRAS Gene MutationUnited States
-
Strata OncologyWithdrawn
-
Cardiff OncologyNo longer availableMetastatic Colorectal Cancer | KRAS Gene Mutation
-
Cardiff OncologyActive, not recruitingPancreatic Ductal AdenocarcinomaUnited States
-
Arch OncologyCompletedMultiple MyelomaUnited States
-
Elevation OncologyTerminatedMetastatic Breast CancerGermany, Spain, United States, Austria, Belgium, Canada
-
Alchemia OncologyUnknown
-
DiabetechCompletedDiabetes Mellitus, Type 1United States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; Southwest Oncology GroupCompletedProstate CancerUnited States, Canada
-
Maastricht Radiation OncologyRecruitingBreast Cancer | Head and Neck Cancer | Anxiety | Lung Cancer | Prostate Cancer | Brain Tumor | FearNetherlands
-
Cullinan Oncology Inc.RecruitingAdvanced Solid TumorUnited States
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) MutationsUnited States, Japan, Spain, Italy, Korea, Republic of, Canada, France, Australia, Germany, United Kingdom, Hong Kong, Turkey
-
Taiho Oncology, Inc.RecruitingPancreatic Cancer | Esophageal Adenocarcinoma | Esophageal Squamous Cell Cancer | Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer | Siewert Type 1 GEJ CancerUnited States, Spain, Germany, France
-
Taiho Oncology, Inc.RecruitingNon-Small Cell Lung CancerUnited States, France, Italy, Korea, Republic of, Japan, Spain, Germany, Netherlands, United Kingdom
-
ALX Oncology Inc.RecruitingBladder Cancer | Urothelial CarcinomaUnited States
-
Children's Oncology GroupNot yet recruitingRecurrent Langerhans Cell Histiocytosis | Refractory Langerhans Cell Histiocytosis
-
RS Oncology LLCRecruitingMesothelioma | Malignant Pleural Mesothelioma | Pleural Effusion, Malignant | Mesotheliomas Pleural | Malignant Pleural Effusion | Mesothelioma; LungUnited Kingdom